The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment

BACKGROUND: Our previous studies of Alzheimer’s disease (AD) suggested that glutamine broadly improves cellular readiness to respond to stress and acts as a neuroprotectant both in vitro and in AD mouse models. We now expand our studies to a second neurodegenerative disease, ataxia-telangiectasia (A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Neurodegener
Autors principals: Chen, Jianmin, Chen, Yanping, Vail, Graham, Chow, Heiman, Zhang, Yang, Louie, Lauren, Li, Jiali, Hart, Ronald P., Plummer, Mark R., Herrup, Karl
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991002/
https://ncbi.nlm.nih.gov/pubmed/27538496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-016-0127-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars